Next Article in Journal
The Oscillatory Spinning Drop Technique. An Innovative Method to Measure Dilational Interfacial Rheological Properties of Brine-Crude Oil Systems in the Presence of Asphaltenes
Next Article in Special Issue
Electrochemical Perspective on Hematite–Malonate Interactions
Previous Article in Journal
Effect of Surfactant Dynamics on Flow Patterns Inside Drops Moving in Rectangular Microfluidic Channels
Previous Article in Special Issue
A pH-Responsive Foam Formulated with PAA/Gemini 12-2-12 Complexes
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Mathematical Modeling of Water-Soluble Astaxanthin Release from Binary Polysaccharide/Gelatin Blend Matrices

1
Department of Biochemistry and Food Chemistry, Faculty of Food Sciences and Biotechnology, University of Life Sciences in Lublin, Skromna 8, 20-704 Lublin, Poland
2
Laboratory of Confocal and Electron Microscopy, Centre for Interdisciplinary Research, Faculty of Science and Health, John Paul II Catholic University of Lublin, Konstantynów 1J, 20-708 Lublin, Poland
*
Author to whom correspondence should be addressed.
Colloids Interfaces 2021, 5(3), 41; https://doi.org/10.3390/colloids5030041
Submission received: 18 June 2021 / Revised: 28 July 2021 / Accepted: 30 July 2021 / Published: 3 August 2021
(This article belongs to the Special Issue Interfacial Phenomena)

Abstract

:
Water-soluble AstaSana astaxanthin (AST) was loaded into 75/25 blend films made of polysaccharides (carboxymethyl cellulose (CMC), gum Arabic (GAR), starch sodium octenyl succinate (OSA), water-soluble soy polysaccharides (WSSP)) and gelatin (GEL) at levels of 0.25, 0.5, and 1%, respectively. Due to the presence of starch granules in the AST formulation, the supplemented films exhibited increased surface roughness as compared to the AST-free films. Apart from the CMC/GEL carrier, the migration of AST to water (25 °C, 32 h) was incomplete. Excluding the CMC-based carrier, the gradual rise in the AST concentration decreased the release rate. The Hopfenberg with time lag model provided the best fit for all release series data. Based on the quarter-release times (t25%), the 0.25% AST-supplemented OSA/GEL film (t25% = 13.34 h) ensured a 1.9, 2.2, and 148.2 slower release compared to the GAR-, WSSP- and CMC-based carriers, respectively. According to the Korsmeyer–Peppas model, the CMC-based films offered a quasi-Fickian release of AST (n < 0.5) with the burst effect (t100% = 0.5–1 h). In general, the release of AST from the other films was multi-mechanistic (n > 0.5), i.e., controlled at least by Fickian diffusion and the polymer relaxation (erosion) mechanism. The 1% AST-added WSSP/GEL system provided the most linear release profile.

Graphical Abstract

1. Introduction

Hydrocolloids are commonly used in almost all major dosage forms including tablets, capsules, suspensions, gels, films, and transdermal patches [1]. Currently, plant origin polysaccharides, due to their abundance, renewability, and biodegradability, are often considered as an alternative material for packaging production, including “biodegr-edible” controlled-release packaging, which is a new technology that relies on releasing active compounds (antimicrobials and antioxidants) at desirable rates to extend the shelf life of food [2]. Edible packaging can be used where the application of plastic packaging is limited, e.g., as coating, casings, capsules, micro- and nano-capsules, sachets for single serve products (e.g., coffee, spices, etc.) that dissolve after exposure to heat, layers separating components in complex food, etc.
Every biopolymer has its own characteristic [3,4]. For example, the easily soluble polysaccharides, such as carboxymethyl cellulose (CMC) and pullulan, offer rapid release (burst effect) of bioactive molecules upon contact with the aqueous medium, while various forms of starch carrier matrices can be fabricated for controlled-release purposes [4,5]. The knowledge of release rate is of utmost relevance, hence a rapid release causes fast consumption of the active compounds within a short time, after which the concentration of active compound required for the effective protective action is not maintained on the food surface; and, conversely, spoilage reactions on the food surface may start if the release of the preservatives from the packaging film is too slow [6].
To cover the shortcomings of some biopolymers, in order to obtain active packaging materials, which are capable of control preservative release for the whole storage period, the material properties are modified by blending, which is a simple and effective way to improve the performance of packaging biomaterials [7,8,9].
In general, gelatin (GEL), as a collagen derivative, forms more mechanically strong films compared to other biopolymers, such as cellulose derivatives, modified starches, gum Arabic (GAR), soy polysaccharides, and soy proteins [7,10]. The GEL films are poorly water-soluble at 25 °C [7], while dissolving immediately in biological fluids at body temperature [11]. Because of the excellent film-forming properties of GEL, many GEL-containing blend materials have been achieved, including the active edible packaging films [12,13,14,15]. The GEL-added polysaccharide films have less water-erodible character, thus exhibit slower release of food preservatives [16,17].
Astaxanthin (ASX) is one of the natural carotenoids present in Haematococcus pluvialis, yeast as well as in hydrobiontes, such as crab, shrimp, and salmon [18]. With its unique antioxidant power, and being superior to vitamin E, β-carotene, and coenzyme Q10 [19], the ASX has attracted great attention in the scientific world. Nowadays, there are many publications describing the pro-healthy properties of ASX [20,21,22]. The technological improvements (e.g., micro-cultivation technologies with less water usage and electricity) in the production and commercialization of ASX has contributed to the market growth. Companies have employed cost-effective technologies to produce synthetic ASX. ASX from algae, synthetic and bacterial sources, is generally recognized as safe (GRAS) by the FDA [23]. Despite the fact that natural ASX has greater antioxidant capacity than the synthetic counterpart [24], the latter is about three times cheaper, more stable, oil-free, and water-soluble. Consequently, over 95% of the ASX available on the market is produced synthetically, whereas naturally produced microalgae ASX represents <1% of the commercial product [25]. On the basis of application, the global market for ASX is categorized into nutraceuticals, cosmetics, aquaculture, animal feed, and others.
Owing to its natural red color and capability of scavenging free radicals, ASX is the preferred choice for the active antioxidant packaging development [17,26] for specific applications, e.g., edible coatings for cheese, nuts, red meat, surimi sticks, etc.
In this work, the release of synthetic water-soluble AstaSana ASX (AST) from binary 75/25 blend films made of polysaccharides (carboxymethyl cellulose (CMC), GAR, starch sodium octenyl succinate (OSA), water-soluble soy polysaccharides (WSSP)) and gelatin (GEL) was determined at 25 °C (the highest predictable food/packaging contact temperature). The data were analysed mathematically by considering eight different release models. A comparative parametric study was performed to better understand the effects of AST concentration (0, 0.25, 0.5, 1%) along with carrier type on the release rate.

2. Materials and Methods

2.1. Materials

The food-grade biopolymers used in this study were: sodium CMC 30 GA (Dow Wolff Cellulosics, Bomlitz, Germany), GAR (Agri-Spray Acacia R, Agrigum International, Old Amersham, UK), starch sodium octenyl succinate Purity Gum 2000 (Ingredion Germany GmbH, Hamburg Germany), WSSP (Gushen Biological Technology Group Co. Ltd, Dezhou, China), and pork GEL (with bloom strength of 240; McCormick-Kamis S.A., Stefanowo, Poland). AstaSana 5% CWS/S-TG (containing astaxanthin, modified food starch, corn starch, glucose syrup, sodium ascorbate, and DL-α-tocopherol) was gifted by DSM Nutritional Products (Heerlen, The Netherlands). Glycerol and 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt (ABTS) were purchased from Sigma Chemical Co. (Saint Louis, MO, USA).

2.2. Film Preparation

The films were prepared according to the previous procedure [17]. Briefly, the aqueous 5% (w/w) polysaccharide/GEL solutions containing glycerol (1% w/w) and AST (0.25, 0.5, 1% w/w) were degassed and cast on leveled polytetrafluoroethylene-coated trays with an area of 4 cm2. The polysaccharide/GEL ratio was 75/25. A constant amount of total solids (0.0125 g/cm2) was placed on the trays in order to maintain film thickness. The film-forming solutions were dried at 25 ± 2 °C and 50 ± 5% relative humidity (RH) for 24 h. The films were peeled from the trays and conditioned in a MLR-350 climatic test chamber (Sanyo Electric Biomedical Co. Ltd., Osaka, Japan) for 48 h under the conditions as above.

2.3. Film Thickness

The thickness of the film samples (4 cm2) was determined using a 547–401 micrometer (Mitotuyo, Tokyo, Japan).

2.4. Scanning Electron Microscopy (SEM) and Light Microscopy

SEM was used in order to visualize the surface of the films, AST powder, and 1% AST aqueous solution. After drying in a Polaron CPD 7501 critical point dryer (Quorum Technologies Ltd., East Sussex, UK), the samples were sputter coated (Polaron SC7620, Quorum Technologies Ltd., East Sussex, UK) with 20–30 nm layer of gold palladium (Au/Pd) and examined using LEO 1430 VP scanning electron microscope (LEO Electron Microscopy Ltd., Cambridge, UK) at following presets: accelerating voltage of 15 kV, aperture size: 30 μm, beam current 30 μm, signal: secondary electron detector, chamber pressure: 10−5 Pa, working distance: 10–13 mm, image resolution: 2048 × 1576 pixel, scanning mode: pixel noise reduction. Additionally, the AST aqueous solution was examined with the Olympus MCKX53 light microscope (Olympus, Tokyo, Japan).
The diameter of the objects was measured using AxioVision Rel. 4.8 software (Carl Zeiss Microscopy GmbH, Göttingen, Germany).

2.5. AST Release Study

The film discs (4 cm2) were shaken with distilled water (25 mL, 25 ± 1 °C, 170 rpm, 32 h) in the shaking incubator (Incu-Shaker Mini, Benchmark Scientific, Inc., Sayreville, NJ, USA). 250 µL of the release media samples were taken at different time points and the absorbance was read at 464 nm using a microplate spectrophotometer (EPOCH 2 Microplate Spectrophotometer, BioTek, Winooski, VT, USA). The release tests were limited to 32 h because of a further progressive spoilage of film samples (the presence of a bad odour coming from the acceptor solution). The analyses were performed in triplicate.

2.6. Mathematical Modeling

DDSolver, i.e., add-in software for Microsoft Excel, was used for modeling the AST release kinetics. Eight mathematical models (Table 1) were chosen to fit the experimental data. The adjusted coefficient of determination (R2adjusted) was used for the selection of the optimal mathematical models, which were used for the determination of the quarter-release times (t25%) [27].

3. Results

3.1. Microstructure and Film Thickness

Consistent with the previous study [14], the surface of the control CMC/GEL film revealed the presence of GEL-rich microspheres with diameters ranging from 13.33 to 26.67 μm (Figure 1). It confirms that CMC and GEL are two incompatible biopolymers [8] that cannot form the homogeneous blend films at the micro-level. In turn, good compatibility (lack of aggregates or undissolved particles) was found for the other polysaccharide/GEL blends. In accordance with the previous studies [7], the surfaces of WSSP-containing film were rough and uneven, which could be attributed to the weak dissolution of the polysaccharide. The AST-added films were more heterogeneous as compared to the controls (Figure 1). Since starch is the component of the AST formulation (Figure 2), it is easy to deduce that the observed round-shaped inequalities were the starch granules. The size of the starch granules in the AST powder and the dehydrated AST solution ranged from 5.71 to 15.71 (Figure 2), which corresponds to the size of corn starch granules [28].
It was found that the CMC75/GEL25 films with higher AST content (0.5–1%) exhibited higher thickness as compared to other carriers (p < 0.05, Table 2). This result may be explained by the fact that the combination of the phase-separated microspheres with the starch granules (from AST) was unable to form a compact film network (Figure 1). However, regardless of the carrier type, no difference (p > 0.05) in thickness was observed between the AST-added and control films.

3.2. Release of AST

Figure 3 and Figure 4 show the cumulative amount (mg/cm2) and percentage of AST released from the films, respectively. It was found that during 32 h dissolution test, only the CMC/GEL carrier offered complete release. Depending on the AST concentration, the 100% release occurred after 0.5–1 h (Figure 4). This result could be easily explained by the fact that CMC dissolves rapidly after coming into contact with water [8]. The t25% values estimated for the CMC-based films ranged from 0.09 to 0.15 h (Table 2). In the case of the other carriers, ~14–89% of the initial dose of AST was released. The slowest release of AST was found for the OSA/GEL (t25% = from 13.34 to >27.26 h) and the WSSP/GEL (t25% = 6.16–50.95 h) carriers (Table 2). This result is likely associated with the partial solubility of these films at 25 °C [7]. It should be noted here that since the release of AST from the 1% AST-added OSA-based film was very slow and incomplete, it was not possible to predict t25% for this system.
Regardless of the AST concentration, the WSSP/GEL film ensured the longest time without AST release (Tlag = 50 min, Figure 4). It suggests a strong physicochemical entrapment of the carotenoid in this matrix. This result confirms our earlier observations, which showed that WSSP-based film offered longer Tlag (thus slower release) than GAR-based carrier [17]. As suggested before, the cause could be the highly branched structure of WSSP [29]. Apart from the 1% AST-added WSSP-based system, the release profiles exhibited a sudden burst of AST. This phenomenon can be attributed to the erosion of the films.
Apart from the CMC-based carrier, the gradual rise in the AST concentration decreased the release rate from the carriers. It seems possible that this result is due to increasing amounts of the starch in the AST-added films; i.e., the starch granules (Figure 1) inhibited access of water molecules to the polymeric matrix, which limited dissolution of AST [17]. The highly erodible character of CMC probably meant that the presence of starch did not affect the dissolution behavior of the CMC/GEL carrier.
Eight mathematical equations (Table 1) were used to the quantitative interpretation of the data obtained from the ASTA release assay. The R2adjusted and the parameter values estimated for the models are presented in Table 3, Table 4, Table 5 and Table 6. It was impossible to fit one optimal model to describe the migration of AST from the particular carrier types, however, based on R2adjusted averages the Hop Tlag model provided the best fit for all release series data (R2adjusted mean = 0.9242). It was found that the Hig Tlag model was the least useful for AST release prediction (R2adjusted mean = 0.6650). Among the tested models, the F-O Fmax, K-P Tlag, Hop Tlag, Log 2, and Wb Fmax were quite suitable for the description of AST release from the CMC-based carrier (R2adjusted = 0.9410–0.9890). The Wb Fmax model ensured the best fit (R2adjusted = 0.9610–0.9890). The shape parameter (β) obtained from the Wb Fmax model, showed that the AST release profile of the 0.25–0.5% AST-added CMC-based films was sigmoid (β > 1), while for the 1% AST-added carrier the release was more parabolic (β < 1). Nevertheless, the differences in the over mentioned shapes of the release curves were barely visible (Figure 4 and Figure 5).
The M-B Tlag model was the best to predict the release of AST from the GAR-based (R2adjusted = 0.9341–0.9380), OSA-based (R2adjusted = 0.8861–0.9461) and WSSP-based films (R2adjusted = 0.9187–0.9967). Interestingly, since the 1% AST-added WSSP/GEL film offered the most linear release profile (Figure 4 and Figure 5), all mathematical models described fairly well the release from this system (R2adjusted = 0.9281–0.9967). The K-P model is often used to analyse the release of the active substance from polymeric dosage forms, when the release mechanism is not well known, or when more than one type of release phenomena could be involved [30]. In planar (thin films) geometry, the released mechanism is described as: (i) quasi-Fickian diffusion (n < 0.5), (ii) Fickian diffusion (n = 0.5), (iii) non-Fickian diffusion (0.5 < n < 1), (iv) case II transport (zero-order release) (n = 1), and (v) super case II transport (n > 1) [31]. It was found that in the case of all CMC-based films, the n values were below 0.5 (Table 5), which implies that release mechanism was non-swellable matrix-diffusion [8,32]. It shows that the very small release exponent (n = 0.007–0.055) is characteristic for the burst release of AST (Figure 5). This result may be explained by the fact that despite the CMC/GEL film has short initial ability to hold water (swelling ≈ 500%), it rapidly dissolves (due to high content of easily soluble polysaccharide fraction) [8], which results in a rapid dissolution of AST in the aqueous medium. This result supports evidence from previous observations [8], which showed that the release of potassium salts of iso-α-acids from the films based on CMC/GEL blends was beyond the limits of the K-P “power law” model (n < 0.5).
The release of AST from the 0.25–0.5% AST-added WSSP-based carrier and was followed by a non-Fickian mechanism. It shows that the AST migration was governed by diffusion and controlled swelling, whose rate was similar. The rearrangement of the polymeric chains occurred slowly, and the diffusion simultaneously caused the time-depended anomalous release [33].
For the GAR- and OSA-based films (regardless of AST concentration), the n value was above 1, which is an indicator of the extreme form of transport (super case II model), i.e., more than one mechanism (swelling, polymer chain disentanglement (relaxation), erosion) was involved in the AST release kinetics. Regarding the GAR-based carrier, the obtained result complies with the previous findings [34,35], which suggested that gelling properties of GAR (at high polymer concentrations) ensure the sustained drug release. Thus, it can be concluded that the water entrapped in the gel strongly affected the diffusional behavior of AST in the GAR-based films. In turn, limited release of AST from the OSA/GEL carrier (~19–46%, depending on the AST concentration) could be attributed to the encapsulation of ASX in the OSA/GEL complexes (coacervates) [36].
As for the 1% AST-added WSSP-based film, it is possible that the bulky amounts of starch granules (from AST) acted as a release modifier. It is known that native starch has multifunctional uses in the different physical forms of carriers serving as the binder, disintegrant, diluents, glidant, and lubricant [37]. Therefore, it is possible that the granules anchored in the film matrix (Figure 1), hindered the contact of dissolution media with WSSP/GEL matrix, which consequently limited erosion of the carrier, thus ASX release was predominately controlled by diffusion (n < 0.5, Table 5).

4. Conclusions

The CMC-based carrier offers a quasi-Fickian release of AST with the burst effect (100% release occurred after 0.5–1 h, depending on the AST concentration). According to the t25%, at the lowest AST concentration (0.25%), the OSA/GEL film offered about 1.9, 2.2, and 148.2 times slower release compared to the GAR-, WSSP- and CMC-based carriers, respectively. The 1% AST-added WSSP-based system had the most linear AST release profile (close to the Z-O kinetics). It suggests that this formulation applied on the high moisture food will maintain the main dose of the carotenoid on the surface, where the oxidation reactions occur the most intensively. It was found that the Hopfenberg with Tlag model provided the best fit for all release series data. The Korsmeyer–Peppas release exponent (n), for the GAR-, OSA-, and WSSP-based films was >0.5, confirming that these carriers ensured more multi-mechanistic AST release than the CMC-based film (n < 0.5).
In summary, this study showed that apart from the CMC/GEL carrier, the migration of AST from the films into the water at 25 °C (the highest predictable food/packaging contact temperature) was incomplete, although the compound was released for more than one day. The release tests were limited only to 32 h because of a further progressive spoilage of film samples (the presence of a bad odour coming from the acceptor solution). Therefore, the accelerated release testing at increased temperature (e.g., 30 °C) can be recommended to rapidly assess and predict “real-time” AST release profiles from the obtained films.
In order to facilitate the selection of suitable candidate material for a particular packaging application, further experimental investigations are needed to estimate the effect of increasing concentration of AST on the optical, mechanical, and barrier properties of the binary polysaccharide/GEL blend films.

Author Contributions

Conceptualization, K.Ł. and D.K.; methodology, D.K.; validation, K.Ł. and D.K.; formal analysis, K.Ł.; investigation, K.Ł. and T.S.; data curation, K.Ł.; writing—original draft preparation, K.Ł.; writing—review and editing, D.K. and B.B.; visualization, K.Ł.; supervision, D.K. and B.B.; project administration, K.Ł.; funding acquisition, K.Ł. All authors have read and agreed to the published version of the manuscript.

Funding

This work was financially supported by the National Science Centre (Poland) under grant number 2019/35/N/NZ9/01795.

Data Availability Statement

The data present in this study are available on request from the first author (Katarzyna Łupina).

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Nyamweya, N.N. Applications of polymer blends in drug delivery. Future J. Pharm. Sci. 2021, 7, 18. [Google Scholar] [CrossRef]
  2. Cutter, C.N. Microbial control by packaging: A review. Crit. Rev. Food Sci. Nutr. 2002, 42, 151–161. [Google Scholar] [CrossRef] [PubMed]
  3. Kowalczyk, D. Biopolymer/candelilla wax emulsion films as carriers of ascorbic acid—A comparative study. Food Hydrocoll. 2016, 52, 543–553. [Google Scholar] [CrossRef]
  4. Kowalczyk, D.; Biendl, M. Physicochemical and antioxidant properties of biopolymer/candelilla wax emulsion films containing hop extract—A comparative study. Food Hydrocoll. 2016, 60, 384–392. [Google Scholar] [CrossRef]
  5. Young, S.; Wong, M.; Tabata, Y.; Mikos, A.G. Gelatin as a delivery vehicle for the controlled release of bioactive molecules. J. Control. Release 2005, 109, 256–274. [Google Scholar] [CrossRef] [PubMed]
  6. Uz, M.; Altinkaya, S.A. Development of mono and multilayer antimicrobial food packaging materials for controlled release of potassium sorbate. LWT—Food Sci. Technol. 2011, 44, 2302–2309. [Google Scholar] [CrossRef] [Green Version]
  7. Łupina, K.; Kowalczyk, D.; Zięba, E.; Kazimierczak, W.; Mężyńska, M.; Basiura-Cembala, M.; Wiącek, A.E. Edible films made from blends of gelatin and polysaccharide-based emulsifiers—A comparative study. Food Hydrocoll. 2019, 96, 555–567. [Google Scholar] [CrossRef]
  8. Kowalczyk, D.; Pytka, M.; Szymanowska, U.; Skrzypek, T.; Łupina, K.; Biendl, M. Release kinetics and antibacterial activity of potassium salts of iso-α-acids loaded into the films based on gelatin, carboxymethyl cellulose and their blends. Food Hydrocoll. 2020, 109, 106104. [Google Scholar] [CrossRef]
  9. Kowalczyk, D.; Kordowska-Wiater, M.; Karaś, M.; Zięba, E.; Mężyńska, M.; Wiącek, A.E. Release kinetics and antimicrobial properties of the potassium sorbate-loaded edible films made from pullulan, gelatin and their blends. Food Hydrocoll. 2020, 101, 105539. [Google Scholar] [CrossRef]
  10. Kowalczyk, D.; Baraniak, B. Effect of candelilla wax on functional properties of biopolymer emulsion films—A comparative study. Food Hydrocoll. 2014, 41, 195–209. [Google Scholar] [CrossRef]
  11. Chiwele, I.; Jones, B.E.; Podczeck, F. The shell dissolution of various empty hard capsules. Chem. Pharm. Bull. 2000, 48, 951–956. [Google Scholar] [CrossRef] [Green Version]
  12. Liu, C.; Huang, J.; Zheng, X.; Liu, S.; Lu, K.; Tang, K.; Liu, J. Heat sealable soluble soybean polysaccharide/gelatin blend edible films for food packaging applications. Food Packag. Shelf Life 2020, 24, 100485. [Google Scholar] [CrossRef]
  13. Jridi, M.; Abdelhedi, O.; Salem, A.; Kechaou, H.; Nasri, M.; Menchari, Y. Physicochemical, antioxidant and antibacterial properties of fish gelatin-based edible films enriched with orange peel pectin: Wrapping application. Food Hydrocoll. 2020, 103, 105688. [Google Scholar] [CrossRef]
  14. Kowalczyk, D.; Szymanowska, U.; Skrzypek, T.; Basiura-Cembala, M.; Łupina, K.; Biendl, M. Edible films based on gelatin, carboxymethyl cellulose, and their blends as carriers of potassium salts of iso-α-acids: Structural, physicochemical and antioxidant properties. Food Hydrocoll. 2021, 115. [Google Scholar] [CrossRef]
  15. Kowalczyk, D.; Skrzypek, T.; Basiura-Cembala, M.; Łupina, K.; Mężyńska, M. The effect of potassium sorbate on the physicochemical properties of edible films based on pullulan, gelatin and their blends. Food Hydrocoll. 2020, 105, 105837. [Google Scholar] [CrossRef]
  16. Łupina, K.; Kowalczyk, D.; Drozłowska, E. Polysaccharide/gelatin blend films as carriers of ascorbyl palmitate—A comparative study. Food Chem. 2020, 333, 127465. [Google Scholar] [CrossRef]
  17. Łupina, K.; Kowalczyk, D.; Kazimierczak, W. Gum Arabic/gelatin and water-soluble soy polysaccharides/gelatin blend films as carriers of astaxanthin—A comparative study of the kinetics of release and antioxidant properties. Polymers 2021, 13, 1062. [Google Scholar] [CrossRef]
  18. Fakhri, S.; Abbaszadeh, F.; Dargahi, L.; Jorjani, M. Astaxanthin: A mechanistic review on its biological activities and health benefits. Pharmacol. Res. 2018, 136, 1–20. [Google Scholar] [CrossRef] [PubMed]
  19. Yamashita, E. Astaxanthin as a Medical Food. Funct. Foods Health Dis. 2013, 3, 254–258. [Google Scholar] [CrossRef]
  20. Landon, R.; Gueguen, V.; Petite, H.; Letourneur, D.; Pavon-Djavid, G.; Anagnostou, F. Impact of Astaxanthin on Diabetes Pathogenesis and Chronic Complications. Mar. Drugs 2020, 18, 357. [Google Scholar] [CrossRef] [PubMed]
  21. Donoso, A.; González-Durán, J.; Muñoz, A.A.; González, P.A.; Agurto-Muñoz, C. Therapeutic uses of natural astaxanthin: An evidence-based review focused on human clinical trials. Pharmacol. Res. 2021, 166. [Google Scholar] [CrossRef]
  22. Faraone, I.; Sinisgalli, C.; Ostuni, A.; Armentano, M.F.; Carmosino, M.; Milella, L.; Russo, D.; Labanca, F.; Khan, H. Astaxanthin anticancer effects are mediated through multiple molecular mechanisms: A systematic review. Pharmacol. Res. 2020, 155, 104689. [Google Scholar] [CrossRef]
  23. Brendler, T.; Williamson, E.M. Astaxanthin: How much is too much? A safety review. Phyther. Res. 2019, 33, 3090–3111. [Google Scholar] [CrossRef] [PubMed]
  24. Capelli, B.; Bagchi, D.; Cysewski, G.R. Synthetic astaxanthin is significantly inferior to algal-based astaxanthin as an antioxidant and may not be suitable as a human nutraceutical supplement. Nutrafoods 2013, 12, 145–152. [Google Scholar] [CrossRef]
  25. Koller, M.; Muhr, A.; Braunegg, G. Microalgae as versatile cellular factories for valued products. Algal Res. 2014, 6, 52–63. [Google Scholar] [CrossRef]
  26. Colín-Chávez, C.; Soto-Valdez, H.; Peralta, E.; Lizardi-Mendoza, J.; Balandrán-Quintana, R. Diffusion of natural astaxanthin from polyethylene active packaging films into a fatty food simulant. Food Res. Int. 2013, 54, 873–880. [Google Scholar] [CrossRef]
  27. Zhang, Y.; Huo, M.; Zhou, J.; Zou, A.; Li, W.; Yao, C.; Xie, S. DDSolver: An add-in program for modeling and comparison of drug dissolution profiles. AAPS J. 2010, 12, 263–271. [Google Scholar] [CrossRef] [Green Version]
  28. Singh, J.; Colussi, R.; McCarthy, O.J.; Kaur, L. Potato Starch and Its Modification. In Advances in Potato Chemistry and Technology, 2nd ed.; Singh, J., Kaur, L., Eds.; Elsevier Inc.: Amsterdam, The Netherlands, 2016; pp. 195–247. ISBN 9780128000021. Available online: https://www.sciencedirect.com/science/article/pii/B978012800002100008X (accessed on 1 February 2021).
  29. Ikeda, S.; Funami, T.; Zhang, G. Visualizing surface active hydrocolloids by atomic force microscopy. Carbohydr. Polym. 2005, 62, 192–196. [Google Scholar] [CrossRef]
  30. Costa, P.; Lobo, J.M.S. Modeling and comparison of dissolution profiles. Eur. J. Pharm. Sci. 2001, 13, 123–133. [Google Scholar] [CrossRef]
  31. Olejnik, A.; Kapuscinska, A.; Schroeder, G.; Nowak, I. Physico-chemical characterization of formulations containing endomorphin-2 derivatives. Amino Acids 2017, 49, 1719–1731. [Google Scholar] [CrossRef] [Green Version]
  32. Permanadewi, I.; Kumoro, A.C.; Wardhani, D.H.; Aryanti, N. Modelling of controlled drug release in gastrointestinal tract simulation. J. Phys. Conf. Ser. 2019, 1295, 012063. [Google Scholar] [CrossRef]
  33. Bruschi, M. Mathematical models of drug release. In Strategies to Modify the Drug Release from Pharmaceutical Systems; Bruschi, M., Ed.; Woodhead Publishing: Cambridge, UK, 2015; pp. 63–86. ISBN 9780081000922. [Google Scholar]
  34. Shah, S.N.H.; Asghar, S.; Choudhry, M.A.; Akash, M.S.H.; Rehman, N.U.; Baksh, S. Formulation and evaluation of natural gum-based sustained release matrix tablets of flurbiprofen using response surface methodology. Drug Dev. Ind. Pharm. 2009, 35, 1470–1478. [Google Scholar] [CrossRef]
  35. Batra, V.; Bhowmick, A.; Behera, B.K.; Ray, A.R. Sustained release of ferrous sulfate from polymer-coated gum arabica pellets. J. Pharm. Sci. 1994, 83, 632–635. [Google Scholar] [CrossRef] [PubMed]
  36. Zhao, Y.; Khalid, N.; Shu, G.; Neves, M.A.; Kobayashi, I.; Nakajima, M. Complex coacervates from gelatin and octenyl succinic anhydride modified kudzu starch: Insights of formulation and characterization. Food Hydrocoll. 2019, 86, 70–77. [Google Scholar] [CrossRef]
  37. Builders, P.F.; Arhewoh, M.I. Pharmaceutical applications of native starch in conventional drug delivery. Starch/Staerke 2016, 68. [Google Scholar] [CrossRef]
Figure 1. SEM images of the surfaces of the AST-free and 1%AST-added binary blend films based on polysaccharides (CMC, GAR, OSA and WSSP) and gelatin (GEL).
Figure 1. SEM images of the surfaces of the AST-free and 1%AST-added binary blend films based on polysaccharides (CMC, GAR, OSA and WSSP) and gelatin (GEL).
Colloids 05 00041 g001
Figure 2. Images of AstaSana powder (A) and the dehydrated AstaSana aqueous solution examined using the scanning electron microscopy (B). The aqueous solution of AstaSana examined using the optical microscopy (C).
Figure 2. Images of AstaSana powder (A) and the dehydrated AstaSana aqueous solution examined using the scanning electron microscopy (B). The aqueous solution of AstaSana examined using the optical microscopy (C).
Colloids 05 00041 g002
Figure 3. Cumulative migration of AST from the binary polysaccharide/GEL blend films into the water at 25 °C.
Figure 3. Cumulative migration of AST from the binary polysaccharide/GEL blend films into the water at 25 °C.
Colloids 05 00041 g003
Figure 4. Percentage release of AST from the binary polysaccharide/GEL blend films into the water at 25 °C.
Figure 4. Percentage release of AST from the binary polysaccharide/GEL blend films into the water at 25 °C.
Colloids 05 00041 g004
Figure 5. Fraction (F) of AST released from binary polysaccharide/GEL blend films according to the Hopfenberg with Tlag (Hop Tlag) and Weibull with Fmax (Wb Fmax) models; experimental (exp) and model predicted data (mod pre).
Figure 5. Fraction (F) of AST released from binary polysaccharide/GEL blend films according to the Hopfenberg with Tlag (Hop Tlag) and Weibull with Fmax (Wb Fmax) models; experimental (exp) and model predicted data (mod pre).
Colloids 05 00041 g005
Table 1. Mathematical models used to describe the dissolution curves [27].
Table 1. Mathematical models used to describe the dissolution curves [27].
ModelEquationParameters
Zero-order with Tlag (Z-O Tlag) F = k 0 · ( t T l a g ) k0, Tlag
First-order with Fmax (F-O Fmax) F = F m a x   ·   ( 1 e k 1   · t ) k1, Fmax
Higuchi with Tlag (Hig Tlag) F = k H · ( t T l a g ) 0.5 kH, Tlag
Hopfenberg with Tlag (Hop Tlag) F = 100   ·   { 1 [ 1 k H B · ( t T l a g ) ] n } kHB, n, Tlag
Korsmeyer–Peppas with Tlag (K-P Tlag) F = k K P   ·   ( t T l a g ) n kKP, n, Tlag
Logistic 2 (Log 2) F = F m a x [ e a + β · log ( t ) ] 1 + e a + β · log ( t ) α, β, Fmax
Makoid–Banakar with Tlag (M-BTlag ) F = k M B · ( t T l a g ) ^ · E x p [ k · ( t T l a g ) ] kMB, n, k, Tlag
Weibull with Fmax (Wb Fmax) F = F m a x · [ 1 e ( t T i ) β α ] α, β, Ti, Fmax
F is the fraction (%) of drug released in time t. k0 is the zero-order release constant; k1 is the first-order release constant; Fmax is the maximum fraction of the drug released at infinite time; Tlag is the lag time prior to drug release. kHB is the combined constant in Hopfenberg model, kHB = k0/(C0 × a0), where k0 is the erosion rate constant, C0 is the initial concentration of drug in the matrix, and a0 is the initial radius for a sphere or cylinder or the half thickness for a slab; n is 1, 2, and 3 for a slab, cylinder, and sphere, respectively; kKP is the release constant incorporating structural and geometric characteristics of the drug-dosage form; n is the diffusional exponent indicating the drug release mechanism; α is the scale factor in Logistic 1 and 2 models; β is the shape factor in Logistic 1 and 2 models. kMB, n, and k are empirical parameters in Makoid–Banakar model (kMB, n, k > 0); α is the scale parameter which defines the time scale of the process; β is the shape parameter which characterizes the curve as either exponential (β = 1; case 1), sigmoid, S-shaped, with upward curvature followed by a turning point (β > 1; case 2), or parabolic, with a higher initial slope and after that consistent with the exponential (β < 1; case 3); Ti is the location parameter which represents the lag time before the onset of the dissolution or release process and in most cases will be near zero.
Table 2. Film thickness and the quarter-release times (t25%) obtained from the best fitting mathematical models.
Table 2. Film thickness and the quarter-release times (t25%) obtained from the best fitting mathematical models.
FilmAST (%)Thickness (µm)t25% (h)
CMC/GEL091.32 ± 3.96 ab-
0.2591.01 ± 3.23 ab0.09 (Wb Fmax)
0.595.88 ± 3.71 b0.15 (Wb Fmax)
194.17 ± 2.19 b0.09 (Wb Fmax)
GAR/GEL088.90 ± 2.40 a-
0.2586.74 ± 3.21 a7.20 (M-B Tlag)
0.587.26 ± 3.87 a22.27 (M-B Tlag)
188.88 ± 2.33 a24.00 (M-B Tlag)
OSA/GEL088.33 ± 1.86 a-
0.2586.39 ± 3.68 a13.34 (M-B Tlag)
0.587.72 ± 2.55 a27.26 (K-P Tlag)
186.67 ± 3.61 an.c. (M-B Tlag)
WSSP/GEL088.88 ± 2.71 a-
0.2588.21 ± 2.02 a6.16 (Log 2)
0.587.57 ± 3.73 a17.46 (Log 2)
186.75 ± 2.10 a50.95 (M-B Tlag)
a,b values with the different superscript letters are significantly different (p < 0.05); n.c.—not calculated; (K-P Tlag) Korsmeyer–Peppas with Tlag; (Log 2) Logistic 2; (M-B Tlag) Makoid–Banakar with Tlag; (Wb Fmax) Weibull with Fmax.
Table 3. Comparison of R2adjusted values obtained from fitting experimental data to the different release models.
Table 3. Comparison of R2adjusted values obtained from fitting experimental data to the different release models.
FilmAST (%)Z-O TlagF-O FmaxHig TlagHop TlagK-P Tlag Log 2 M-B TlagWb Fmax
CMC/GEL0.250.21050.95030.24260.95750.94940.96060.76100.9610
0.50.21940.94810.25670.98690.94100.98720.75170.9890
10.26420.98240.30990.98240.94570.98210.96210.9829
GAR/GEL0.250.88990.58670.78990.92380.93040.63890.93800.9180
0.50.77800.53150.36890.92200.86420.51420.93410.7953
10.86990.82890.78640.92310.83970.83970.93560.9106
OSA/GEL0.250.93350.87290.81390.93140.93130.87360.94610.9287
0.50.88520.79700.74720.88810.89060.80930.88610.7963
10.59540.59110.83260.84460.84110.84040.89800.7422
WSSP/GEL0.250.85230.92480.91920.89560.91620.92750.91870.9226
0.50.88710.94120.92970.90370.93020.94390.93890.9425
10.92810.96270.98320.93150.98270.97500.99670.9817
Average R2adjusted0.69280.82650.66500.9242 *0.91350.85770.90560.9059
* the best fit among the all models.
Table 4. Kinetic parameters obtained from two-parameter modeling.
Table 4. Kinetic parameters obtained from two-parameter modeling.
FilmAST (%)Z-O Tlag F-O FmaxHig Tlag
k0Tlagk1FmaxkHTlag
CMC/GEL0.251.603−41.7034.399101.59417.865−12.630
0.51.740−36.0493.478100.95718.494−9.997
11.790−34.2933.23099.91918.721−9.220
GAR/GEL0.251.920−8.1240.008355.69911.542−1.825
0.50.959−7.7860.0000915,279.7476.2651.758
10.987−3.0070.0000814,031.3388.90613.589
OSA/GEL0.251.414−4.0410.02785.4338.2591.882
0.50.770−4.4650.01385.5074.5551.783
10.354−1.1550.0000313,204.8296.94123.867
WSSP/GEL0.252.077−2.0430.08462.25111.1000.840
0.51.077−1.6500.06634.9395.6130.840
10.443−2.5180.07014.4382.3920.670
Table 5. Kinetic parameters obtained from three-parameter modeling.
Table 5. Kinetic parameters obtained from three-parameter modeling.
FilmAST (%)Hop TlagK-P TlagLog 2
kHBnTlagkKPnTlagαβFmax
CMC/GEL0.252.2241.433−0.00397.5410.0170.1704.9476.096101.023
0.52.8050.421−0.02598.1000.0070.3308.47211.74099.556
10.009371.6890.00886.5850.0550.1402.5523.563100.352
GAR/GEL0.250.0210.525−14.1330.0002.904−45.281−7.4651.01625,582.192
0.50.0170.160−26.1100.0003.321−44.884−9.9422.38224,495.904
10.0230.222−7.1820.3721.3480.006−10.4863.11213,213.903
OSA/GEL0.250.0121.243−3.7301.1171.062−4.771−8.5141.69319,250.461
0.50.0170.336−6.4490.0471.686−13.899−8.7601.60915,235.496
10.0260.051−6.1650.0003.982−0.068−17.13310.354118.171
WSSP/GEL0.250.000212.634−0.43911.0510.5010.840−3.5594.06060.547
0.50.000396.451−0.9014.4540.5770.696−4.1104.29332.359
10.000122.841−2.1502.4840.4870.670−3.8761.48983.440
Table 6. Kinetic parameters obtained from four-parameter modeling.
Table 6. Kinetic parameters obtained from four-parameter modeling.
FilmAST (%)M-B TlagWb Fmax
kMBnkTlagαβTiFmax
CMC/GEL0.2582.4880.2340.0230.0080.0572.112−0.053100.652
0.578.7440.2610.0250.0083.74812.760−0.85899.641
189.0400.0970.0080.1400.3210.8580.02799.944
GAR/GEL0.2518.160−0.058−0.055−0.77517,018.1122.012−23.973468.274
0.512.085−0.442−0.089−1.8221309.0711.554−14.722153.488
14.7940.009−0.0680.0033059.9061.849−10.398132.949
OSA/GEL0.250.0013.7570.066−15.3536993.8981.065−4.7807756.062
0.50.1281.393−0.005−11.203110.3190.7220.027255.772
10.600−0.333−0.147−0.01425,028.5322.473−4.12763.672
WSSP/GEL0.256.9690.8190.0230.62221.5041.4090.00154.429
0.51.5751.1970.0380.01338.2431.561−0.06728.572
13.8250.162−0.0250.84098.1990.4950.670243.555
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Łupina, K.; Kowalczyk, D.; Skrzypek, T.; Baraniak, B. Mathematical Modeling of Water-Soluble Astaxanthin Release from Binary Polysaccharide/Gelatin Blend Matrices. Colloids Interfaces 2021, 5, 41. https://doi.org/10.3390/colloids5030041

AMA Style

Łupina K, Kowalczyk D, Skrzypek T, Baraniak B. Mathematical Modeling of Water-Soluble Astaxanthin Release from Binary Polysaccharide/Gelatin Blend Matrices. Colloids and Interfaces. 2021; 5(3):41. https://doi.org/10.3390/colloids5030041

Chicago/Turabian Style

Łupina, Katarzyna, Dariusz Kowalczyk, Tomasz Skrzypek, and Barbara Baraniak. 2021. "Mathematical Modeling of Water-Soluble Astaxanthin Release from Binary Polysaccharide/Gelatin Blend Matrices" Colloids and Interfaces 5, no. 3: 41. https://doi.org/10.3390/colloids5030041

Article Metrics

Back to TopTop